Story perspectives

Targeting FSP1: A Breakthrough in Melanoma Treatment

11/6/2025

39 4

Summary

Story summary

Researchers at Harvard T.H. Chan School of Public Health find that metastatic melanoma cells in lymph nodes depend on ferroptosis suppressor protein 1 (FSP1) to survive.
Inhibiting FSP1 could yield cancer treatments tailored to metastatic tumors.
Using in vivo models, the researchers show that targeting FSP1 significantly reduces lymph node tumor growth.
The study marks a significant advancement in understanding cancer metastasis and developing effective therapies.

1 of 1

Story summary

Researchers at Harvard T.H. Chan School of Public Health find that metastatic melanoma cells in lymph nodes depend on ferroptosis suppressor protein 1 (FSP1) to survive.
Inhibiting FSP1 could yield cancer treatments tailored to metastatic tumors.
Using in vivo models, the researchers show that targeting FSP1 significantly reduces lymph node tumor growth.
The study marks a significant advancement in understanding cancer metastasis and developing effective therapies.